GLPBio

L-Thyroxine

Catalog No.: GC11268Purity:>98.00%Synonyms: Levothyroxine, LT4, NSC 36397
L-Thyroxine is a synthetic thyroid hormone that mimics the natural thyroxine secreted by the thyroid gland and plays a crucial role in regulating metabolism and promoting growth and development. L-Thyroxine is commonly used to treat hypothyroidism and other thyroid-related diseases.

Products are for research use only. Not for human use. We do not sell to patients.


L-Thyroxine
Cas No.: 51-48-9
10mM (in 1mL DMSO)In Stock
$39.00
1
500mgIn Stock
$54.00
1
1gIn Stock
$77.00
1

Citations

No citations are currently available for this product. Below are selected publications citing GlpBio products.
  • Nature cover
    Nature
    641, 529–536 (2025)
  • Nature cover
    Nature
    628, 630–638 (2024)
  • Nature cover
    Nature
    632, 686–694 (2024)
  • Nature cover
    Nature
    618, 1017–1023 (2023)
  • Nature cover
    Nature
    610, 366–372 (2022)
  • Cell cover
    Cell
    187(9):2288-2304 (2024)
  • Cell cover
    Cell
    183(7):1867-1883 (2020)
  • Science cover
    Science
    388(6745) (2025)
  • Science cover
    Science
    387(6739) (2025)
  • Science cover
    Science
    387(6734) (2025)
  • Cell Research cover
    Cell Research
    35, 97–116 (2025)
  • Cell Research cover
    Cell Research
    34, 683–706 (2024)
  • Cell Research cover
    Cell Research
    33, 273–287 (2023)
  • Cell Research cover
    Cell Research
    33, 546–561 (2023)
  • Cell Research cover
    Cell Research
    33, 904–922 (2023)
  • Cell Research cover
    Cell Research
    31, 1291–1307 (2021)

Description

L-Thyroxine is a synthetic thyroid hormone that mimics the natural thyroxine secreted by the thyroid gland and plays a crucial role in regulating metabolism and promoting growth and development[1]. L-Thyroxine is commonly used to treat hypothyroidism and other thyroid-related diseases[2]. Additionally, L-Thyroxine is used in diagnostic tests for thyroid function[3] and has been shown to protect myocardial function[4].

In vitro, treatment of U2OS and MG63 osteoblast-like cells with L-Thyroxine (2.5–10μM) for 1 hour significantly increased the expression of Angiopoietin-1 (Ang1) in a dose-dependent manner. L-Thyroxine also significantly enhanced alkaline phosphatase (ALP) activity and cell mineralization capacity. Moreover, it significantly upregulated the expression of osteoblast-related protein markers, such as COL1A1, OC, BSP, Dlx5, Runx2, and OSX[5]. When human bronchial smooth muscle cells (ASM) were treated with L-Thyroxine (1–100nM) in combination with TGF-β1 (2ng/ml) for 28 hours, L-Thyroxine (100nM) significantly enhanced the proliferative response of ASM cells and reduced the expression of contractile proteins induced by TGF-β1 [6].

In vivo, L-Thyroxine (1μg/kg) was administered subcutaneously to mice, which were then exposed to gamma radiation (6Gy) or intraperitoneally injected with cisplatin (15mg/kg) to induce nephrotoxicity. L-Thyroxine significantly improved elevated renal function biomarkers, oxidative stress, and protected renal tissue from subsequent cellular damage[7]. In Ames dwarf mice, L-Thyroxine (0.1μg/g) in combination with growth hormone (GH, 6μg/g) was administered via subcutaneous injection twice a week starting at 2 weeks of age for 6 weeks. This treatment significantly promoted the growth of Ames dwarf mice[8].

References:
[1] Darbinyan L, Simonyan K, Hambardzumyan L, et al. Impact of L-thyroxine on hippocampal activity, morphology, and behavioral performance in thyroidectomized rats. Metab Brain Dis. 2025 Mar 10;40(3):140.
[2] McDermott MT. Hypothyroidism. Ann Intern Med. 2020 Jul 7;173(1):ITC1-ITC16.
[3] Fugazzola L, Persani L, Mannavola D, et al. Recombinant human TSH testing is a valuable tool for differential diagnosis of congenital hypothyroidism during L-thyroxine replacement. Clin Endocrinol (Oxf). 2003 Aug;59(2):230-6.
[4] Wang Y, Zhu S, Liu H, et al. Thyroxine Alleviates Energy Failure, Prevents Myocardial Cell Apoptosis, and Protects against Doxorubicin-Induced Cardiac Injury and Cardiac Dysfunction via the LKB1/AMPK/mTOR Axis in Mice. Dis Markers. 2019 Dec 16;2019:7420196.
[5] Park SH, Lee J, Kang MA, et al. Potential of l-thyroxine to differentiate osteoblast-like cells via Angiopoietin1. Biochem Biophys Res Commun. 2016 Sep 23;478(3):1409-15.
[6] Dekkers BG, Naeimi S, Bos IS, et al. L-thyroxine promotes a proliferative airway smooth muscle phenotype in the presence of TGF-β1. Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L301-6.
[7] El-Hamoly T, El-Sharawy DM, El Refaye MS, et al. L-thyroxine modifies nephrotoxicity by regulating the apoptotic pathway: The possible role of CD38/ADP-ribosyl cyclase-mediated calcium mobilization. PLoS One. 2017 Sep 11;12(9):e0184157.
[8] Do A, Menon V, Zhi X, Gesing A, et al. Thyroxine modifies the effects of growth hormone in Ames dwarf mice. Aging (Albany NY). 2015 Apr;7(4):241-55.

Protocol

Cell experiment [1]:

Cell lines

Human airway smooth muscle (ASM) cells

Preparation Method

ASM cells were cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with streptomycin (50U/ml), penicillin (50µg/ml), and fetal bovine serum (10% vol/vol) at 37°C, 5% CO₂. Cells were serum-starved for 72 hours in serum-free DMEM supplemented with streptomycin, penicillin, and 1% ITS (insulin, transferrin, selenium) before treatment. Cell treated with L-Thyroxine (T4) at 100nM in combination with TGF-β1 (2ng/ml) for 28 hours.

Reaction Conditions

100nM; 28h

Applications

L-Thyroxine significantly increased ASM cell proliferation in the presence of TGF-β1. L-Thyroxine also decreased the expression of contractile proteins (smooth muscle α-actin and calponin) in TGF-β1-treated cultures.

Animal experiment [1]:

Animal models

Ames dwarf (df/df) mice

Preparation Method

Juvenile Ames dwarf mice (both male and female) were treated with a combination of growth hormone (GH, 6μg/g body weight) and L-Thyroxine (0.1μg/g body weight) via subcutaneous injections. GH was administered twice daily, while L-Thyroxine was given three times per week. The treatment started at 2 weeks of age and continued for 6 weeks.

Dosage form

0.1μg/g body weight; subcutaneous injections

Applications

The combination treatment with GH and L-Thyroxine significantly increased body weight in Ames dwarf mice. GH + L-Thyroxine treatment reduced the expression of genes such as insulin receptor (IR), insulin receptor substrate-1 (IRS-1), phosphoinositide 3-kinase (PI3K), and GLUT4 in these tissues, compared to GH alone.

References:
[1] Dekkers BG, Naeimi S, Bos IS, et al. L-thyroxine promotes a proliferative airway smooth muscle phenotype in the presence of TGF-β1. Am J Physiol Lung Cell Mol Physiol. 2015 Feb 1;308(3):L301-6.
[2] Thyroxine modifies the effects of growth hormone in Ames dwarf mice. Aging (Albany NY). 2015 Apr;7(4):241-55.

Product Documents

Purity:>98.00%Appearance:A solid

Chemical Properties

CAS No.
51-48-9
Synonyms
Levothyroxine, LT4, NSC 36397
Chemical Name
(2S)-2-amino-3-[4-(4-hydroxy-3,5-diiodophenoxy)-3,5-diiodophenyl]propanoic acid
SMILES
C1=C(C=C(C(=C1I)OC2=CC(=C(C(=C2)I)O)I)I)CC(C(=O)O)N
Molecular Formula
C15H11I4NO4
Molecular Weight
776.87
Solubility
≥ 27.35mg/mL in DMSO
Storage
Store at 2-8°C
General tips
Select a suitable solvent according to the product solubility data. Once prepared, aliquot the stock solution to avoid repeated freeze-thaw cycles.
Use stock solutions within 6 months when stored at -80°C or within 1 month when stored at -20°C.
To improve solubility, warm the tube to 37°C and sonicate it for an appropriate period.
Shipping Condition
Evaluation samples are shipped with blue ice. Other available sizes are shipped at room temperature or with blue ice upon request.

CalculatorsMolarity / Dilution / Molecular Weight / Unit Conversion / In Vivo Formulation / Solubility

g/mol

Reviews

Review for L-Thyroxine

Rating: 5
  • 5 Star100%
  • 4 Star0%
  • 3 Star0%
  • 2 Star0%
  • 1 Star0%